Afruja Ahad

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Pluripotent Stem Cells

Positive Breast Cancer

Epidermal Growth Factor Receptor

Top Venues

ACS pharmacology & translational science

This page only lists publications with an associated author ORCID identifier.

Publications

Nazia Nayeem, Sami Sauma, Afruja Ahad, Rachele Rameau, Sophia Kebadze, Mark Bazett, Brian J Park, Patrizia Casaccia, Swayam Prabha, Karen Hubbard, Maria Contel
Insights into Mechanisms and Promising Triple Negative Breast Cancer Therapeutic Potential for a Water-Soluble Ruthenium Compound. ACS pharmacology & translational science 7 (5) (2024)
Afruja Ahad, Hiwa K Saeed, Virginia Del Solar, Javier E López-Hernández, Alexa Michel, Joshua Mathew, Jason S Lewis, Maria Contel
Correction to "Shifting the Antibody-Drug Conjugate Paradigm: A Trastuzumab-Gold-Based Conjugate Demonstrates High Efficacy against Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Mouse Model". ACS pharmacology & translational science 7 (1) (2024)
Nazia Nayeem, Sami Sauma, Afruja Ahad, Rachele Rameau, Sophia Kebadze, Mark Bazett, Brian J Park, Patrizia Casaccia, Swayam Prabha, Karen Hubbard, Maria Contel
Insights into Mechanisms and Promising Triple Negative Breast Cancer Therapeutic Potential for a Water-Soluble Ruthenium Compound. ACS pharmacology & translational science 7 (5) (2024)
Nazia Nayeem, Sami Sauma, Afruja Ahad, Rachele Rameau, Sophia Kebadze, Mark Bazett, Brian J Park, Patrizia Casaccia, Swayam Prabha, Karen Hubbard, Maria Contel
Insights into Mechanisms and Promising Triple Negative Breast Cancer Therapeutic Potential for a Water-Soluble Ruthenium Compound. ACS pharmacology & translational science 7 (5) (2024)
Afruja Ahad, Hiwa K Saeed, Virginia Del Solar, Javier E López-Hernández, Alexa Michel, Joshua Mathew, Jason S Lewis, Maria Contel
Correction to "Shifting the Antibody-Drug Conjugate Paradigm: A Trastuzumab-Gold-Based Conjugate Demonstrates High Efficacy against Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Mouse Model". ACS pharmacology & translational science 7 (1) (2024)
Afruja Ahad, Hiwa K Saeed, Virginia Del Solar, Javier E López-Hernández, Alexa Michel, Joshua Mathew, Jason S Lewis, Maria Contel
Correction to "Shifting the Antibody-Drug Conjugate Paradigm: A Trastuzumab-Gold-Based Conjugate Demonstrates High Efficacy against Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Mouse Model". ACS pharmacology & translational science 7 (1) (2024)
Afruja Ahad, Hiwa K Saeed, Virginia Del Solar, Javier E López-Hernández, Alexa Michel, Joshua Mathew, Jason S Lewis, Maria Contel
Shifting the Antibody-Drug Conjugate Paradigm: A Trastuzumab-Gold-Based Conjugate Demonstrates High Efficacy against Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Mouse Model. ACS pharmacology & translational science 6 (12) (2023)